$6.00 0.51 (+9.29%)
11/6/2009 4:00 PM

Micromet, Inc. (MITI)

CAPS Rating: 2 out of 5

Current Price $6.00 Mkt Cap $412.12M
Open $5.43 P/E Ratio 0.00
Prev. Close $5.49 Div. (Yield) N/A (N/A)
Daily Range $5.43 - $6.02 Volume 366,989
52-Wk Range $2.25 - $8.48 Avg. Daily Vol. 263,000

MITI News and Commentary

Related News and Articles

Caps

How do you think MITI will perform vs the S&P 500?

Add Stock to Watchlist

All Members

63 Outperform
26 Underperform
 

All-Star Members

20 Outperform
19 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top MITI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

postbusters (80.24)
Submitted August 20, 2008

I've been in MITI since Dec 07. Potential of BITE is amazing and although MT103 is their lead candidate, they have many BITE platforms in development.

Check out the Science Magazine article that just rocketed the stock into the high 5's… More

3 Comments | Reply | Report this Post

TheParadox (98.27)
Submitted September 24, 2008

The worst company on earth.

0 Comments | Reply | Report this Post
MITI VS S&P 500 (SPY)

Fools bullish on MITI are also bullish on:

Fools bearish on MITI are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about MITI.

Recs

0
Member Avatar nibs61 (68.00) Submitted: 11/4/2009 8:22:30 AM : Outperform Start Price: $5.19 MITI Score: +14.07

They have some very exciting cancer drugs in the works. If they get approved you can take a nice ride.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar EclecticRecluse (75.00) Submitted: 10/26/2009 6:06:17 PM : Underperform Start Price: $5.38 MITI Score: -11.43

Pullback Likely on Relatively Weak Stock

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar NarGuy (61.89) Submitted: 7/19/2009 9:35:40 PM : Outperform Start Price: $4.93 MITI Score: +8.02

Innovative technology, using antibodies to make the immune system attack cancer cells could be a major breakthrough, plus they have had positive results in clinical trials

Report this Post 0 Comments | Reply | Permalink
View All 19 Pitches »

Leaderboard

Find the members with the highest scoring picks in MITI.

Score Leader

TrackLadenburg

TrackLadenburg (46.65) Score: +109.35

The Score Leader is the member with the highest score across all their picks in MITI.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
German584 < 20 7/17/2008 Outperform NS $3.82 +57.07% -11.45% +68.52
daligood 56.72 7/17/2008 Outperform NS $3.82 +57.07% -11.42% +68.49
xpressstock < 20 8/11/2008 Outperform NS $4.03 +48.88% -14.63% +63.51
pookerific < 20 7/24/2008 Outperform 3Y $4.09 +46.70% -12.72% +59.42
kingbuzzo < 20 7/24/2008 Outperform 3W $4.14 +44.96% -12.46% +57.42
noc314 33.68 5/1/2009 Outperform 3M $3.37 +78.04% +23.80% +54.24
jbayj < 20 7/28/2008 Outperform NS $4.36 +37.61% -11.92% +49.54
johnsyros 84.73 5/26/2009 7/3/2009 Outperform 3M $3.69 +62.60% +22.50% +40.10
MessyBurrito 71.60 4/24/2009 Outperform 3M $3.66 +63.93% +25.83% +38.10
1st2 < 20 1/8/2009 Outperform NS $3.87 +55.04% +20.61% +34.43
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackLadenburg 46.65 10/29/2009 Outperform NS $5.37 +11.73% +1.55% +10.19
TrackZacks 69.52 6/19/2009 Outperform 3M $4.53 +32.45% +16.95% +15.50 1 Comment
TrackMerriman < 20 3/25/2009 Outperform NS $2.80 +114.29% +33.11% +81.17
TrackLadenburg 46.65 10/13/2008 Outperform NS $4.70 +73.83% +15.13% +58.70 9/21/2009 @ $8.17
TrackRBCCapMkts 81.74 9/12/2008 Outperform NS $5.25 +14.29% -11.08% +25.37
TrackRothCapital 75.81 8/8/2008 Outperform NS $4.27 +40.52% -12.67% +53.18
TrackLadenburg 46.65 8/7/2008 Outperform NS $4.30 +40.00% -0.46% +40.46 8/18/2008 @ $6.02

Featured Broker Partners